About Nimble Science
Nimble Science is a company based in Calgary (Canada) founded in 2018 by Sabina Bruehlmann and Joseph Wang. Nimble Science has raised $2.7 million across 1 funding round from investors including University of Calgary, Fusion Fund and First Spark Ventures. Nimble Science offers products and services including SIMBA GI Platform, Biopharma Services, and Nutrition Services. Nimble Science operates in a competitive market with competitors including Denali Therapeutics, Poseida Therapeutics, Castle Biosciences, Juno Therapeutics and Unity Biotechnology, among others.
- Headquarter Calgary, Canada
- Founders Sabina Bruehlmann, Joseph Wang
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$2.7 M (USD)
in 1 rounds
-
Latest Funding Round
$2.7 M (USD), Seed
Apr 04, 2023
-
Investors
University of Calgary
& 10 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Nimble Science
Nimble Science offers a comprehensive portfolio of products and services, including SIMBA GI Platform, Biopharma Services, and Nutrition Services.
Autonomous capsule for collecting multi-omic data from small intestine.
Partnerships for biopharma and nutrition data analysis.
Support for validating microbiome changes in nutrition.
People of Nimble Science
Unlock access to complete
Software Development Team
2 people
Leadership Team
1 people
Data Analysis and Operations Team
1 people
Unlock access to complete
Funding Insights of Nimble Science
Nimble Science has successfully raised a total of $2.7M through 1 strategic funding round. The most recent funding activity was a Seed round of $2.7 million completed in April 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Seed — $2.7M
-
First Round
First Round
(04 Apr 2023)
- Investors Count 11
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2023 | Amount | Seed - Nimble Science | Valuation | Fusion Fund |
Investors in Nimble Science
Nimble Science has secured backing from 11 investors, including venture fund and institutional investors. Prominent investors backing the company include University of Calgary, Fusion Fund and First Spark Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investment in early-stage startups focusing on healthcare, AI, and industrial technology.
|
Founded Year | Domain | Location | |
|
A venture capital fund focused on deep tech innovations is managed.
|
Founded Year | Domain | Location | |
|
Venture capital investing and portfolio management services for accredited investors.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Nimble Science
Financial Statements - Nimble Science
Nimble Science Comparisons
Competitors of Nimble Science
Nimble Science operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Denali Therapeutics, Poseida Therapeutics, Castle Biosciences, Juno Therapeutics and Unity Biotechnology, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Neurodegenerative disease therapies are developed for Alzheimer's, ALS, and Parkinson's.
|
|
| domain | founded_year | HQ Location |
Developer of gene therapies for treating cancer and liver orphan disease by using gene editing technologies
|
|
| domain | founded_year | HQ Location |
Precision diagnostic and prognostic tests are developed by Castle Biosciences.
|
|
| domain | founded_year | HQ Location |
CAR T-cell and T-cell receptor immunotherapies for cancer are developed.
|
|
| domain | founded_year | HQ Location |
Therapeutics for aging diseases are developed by targeting senescent cells.
|
|
| domain | founded_year | HQ Location |
Diagnostic services are provided through laboratories and radiology units.
|
Latest news on Nimble Science
Frequently Asked Questions about Nimble Science
Nimble Science was founded in 2018 and raised its 1st funding round 5 years after it was founded.
Nimble Science is headquartered in Calgary, Canada. It is registered at Calgary, Alberta, Canada.
Sabina Bruehlmann is the current CEO of Nimble Science. They have also founded this company.
Nimble Science is a funded company, having raised a total of $2.7M across 1 funding round to date. The company's 1st funding round was a Seed of $2.7M, raised on Apr 04, 2023.
Nimble Science was founded in 2018 in Calgary, Canada. Operations center on biotechnology for gut health, where probiotic-based medicines, novel capsules, and small intestine sampling tools are developed. Gut microorganisms are sequenced and mapped, while biomarkers are collected to enable personalised treatments. Diagnostic innovations are also pursued to support microbiome analysis in the healthcare sector.
Nimble Science's top competitors include Juno Therapeutics, Poseida Therapeutics and Denali Therapeutics.
Nimble Science offers SIMBA GI Platform, Biopharma Services, and Nutrition Services.
Nimble Science has 11 investors. Key investors include University of Calgary, Fusion Fund, First Spark Ventures, Alumni Ventures, and Joyance Partners.